Annual Total Assets
$4.24 B
+$410.10 M+10.71%
December 31, 2024
Summary
- As of February 20, 2025, ALNY annual total assets is $4.24 billion, with the most recent change of +$410.10 million (+10.71%) on December 31, 2024.
- During the last 3 years, ALNY annual total assets has risen by +$596.68 million (+16.38%).
- ALNY annual total assets is now at all-time high.
Performance
ALNY Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Assets
$4.24 B
+$34.94 M+0.83%
December 31, 2024
Summary
- As of February 20, 2025, ALNY quarterly total assets is $4.24 billion, with the most recent change of +$34.94 million (+0.83%) on December 31, 2024.
- Over the past year, ALNY quarterly total assets has increased by +$410.10 million (+10.71%).
- ALNY quarterly total assets is now at all-time high.
Performance
ALNY Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Assets Formula
Total Assets = Current Assets + Non-Current Assets
ALNY Total Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.7% | +10.7% |
| 3 y3 years | +16.4% | +10.7% |
| 5 y5 years | +77.0% | +10.7% |
ALNY Total Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.6% | at high | +27.3% |
| 5 y | 5-year | at high | +77.0% | at high | +86.0% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Alnylam Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $4.24 B(+10.7%) | $4.24 B(+0.8%) |
| Sep 2024 | - | $4.21 B(+4.9%) |
| Jun 2024 | - | $4.01 B(+4.8%) |
| Mar 2024 | - | $3.82 B(-0.1%) |
| Dec 2023 | $3.83 B(+8.0%) | $3.83 B(-0.2%) |
| Sep 2023 | - | $3.84 B(+12.8%) |
| Jun 2023 | - | $3.40 B(+0.3%) |
| Mar 2023 | - | $3.39 B(-4.4%) |
| Dec 2022 | $3.55 B(-2.7%) | $3.55 B(+0.3%) |
| Sep 2022 | - | $3.54 B(+6.2%) |
| Jun 2022 | - | $3.33 B(-3.0%) |
| Mar 2022 | - | $3.43 B(-5.8%) |
| Dec 2021 | $3.64 B(+6.9%) | $3.64 B(+4.9%) |
| Sep 2021 | - | $3.47 B(-1.1%) |
| Jun 2021 | - | $3.51 B(+7.8%) |
| Mar 2021 | - | $3.26 B(-4.5%) |
| Dec 2020 | $3.41 B(+42.2%) | $3.41 B(+3.0%) |
| Sep 2020 | - | $3.31 B(-2.0%) |
| Jun 2020 | - | $3.37 B(+48.0%) |
| Mar 2020 | - | $2.28 B(-4.8%) |
| Dec 2019 | $2.40 B(+52.1%) | $2.40 B(-5.8%) |
| Sep 2019 | - | $2.54 B(-6.4%) |
| Jun 2019 | - | $2.72 B(+34.9%) |
| Mar 2019 | - | $2.01 B(+27.9%) |
| Dec 2018 | $1.57 B(-21.1%) | $1.57 B(-6.0%) |
| Sep 2018 | - | $1.68 B(-6.4%) |
| Jun 2018 | - | $1.79 B(-7.0%) |
| Mar 2018 | - | $1.92 B(-3.6%) |
| Dec 2017 | $1.99 B(+58.0%) | $1.99 B(+46.9%) |
| Sep 2017 | - | $1.36 B(-5.3%) |
| Jun 2017 | - | $1.43 B(+26.5%) |
| Mar 2017 | - | $1.13 B(-10.2%) |
| Dec 2016 | $1.26 B(-8.9%) | $1.26 B(-3.8%) |
| Sep 2016 | - | $1.31 B(-5.0%) |
| Jun 2016 | - | $1.38 B(+5.0%) |
| Mar 2016 | - | $1.32 B(-5.0%) |
| Dec 2015 | $1.39 B(+28.4%) | $1.39 B(-3.5%) |
| Sep 2015 | - | $1.44 B(-6.2%) |
| Jun 2015 | - | $1.53 B(-6.0%) |
| Mar 2015 | - | $1.63 B(+50.9%) |
| Dec 2014 | $1.08 B | $1.08 B(+9.5%) |
| Sep 2014 | - | $986.36 M(-4.5%) |
| Jun 2014 | - | $1.03 B(-4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $1.08 B(+156.9%) |
| Dec 2013 | $420.53 M(+46.3%) | $420.53 M(-6.0%) |
| Sep 2013 | - | $447.50 M(-3.3%) |
| Jun 2013 | - | $462.56 M(-1.9%) |
| Mar 2013 | - | $471.58 M(+64.0%) |
| Dec 2012 | $287.52 M(+2.0%) | $287.52 M(-10.8%) |
| Sep 2012 | - | $322.35 M(+1.2%) |
| Jun 2012 | - | $318.48 M(-6.4%) |
| Mar 2012 | - | $340.30 M(+20.7%) |
| Dec 2011 | $281.92 M(-28.3%) | $281.92 M(-9.1%) |
| Sep 2011 | - | $310.22 M(-9.0%) |
| Jun 2011 | - | $340.83 M(-7.6%) |
| Mar 2011 | - | $369.05 M(-6.2%) |
| Dec 2010 | $393.26 M(-18.3%) | $393.26 M(-4.7%) |
| Sep 2010 | - | $412.61 M(-6.3%) |
| Jun 2010 | - | $440.18 M(-5.0%) |
| Mar 2010 | - | $463.41 M(-3.7%) |
| Dec 2009 | $481.38 M(-13.2%) | $481.38 M(-2.9%) |
| Sep 2009 | - | $495.67 M(-4.4%) |
| Jun 2009 | - | $518.65 M(-6.5%) |
| Mar 2009 | - | $554.53 M(-0.0%) |
| Dec 2008 | $554.68 M(+12.3%) | $554.68 M(-4.4%) |
| Sep 2008 | - | $580.18 M(+0.0%) |
| Jun 2008 | - | $580.05 M(+19.3%) |
| Mar 2008 | - | $486.26 M(-1.5%) |
| Dec 2007 | $493.79 M(+105.7%) | $493.79 M(-2.2%) |
| Sep 2007 | - | $505.09 M(+129.9%) |
| Jun 2007 | - | $219.66 M(-3.4%) |
| Mar 2007 | - | $227.34 M(-5.3%) |
| Dec 2006 | $240.01 M(+144.0%) | $240.01 M(+66.1%) |
| Sep 2006 | - | $144.53 M(-1.8%) |
| Jun 2006 | - | $147.11 M(-4.3%) |
| Mar 2006 | - | $153.69 M(+56.3%) |
| Dec 2005 | $98.35 M(+48.8%) | $98.35 M(+127.4%) |
| Sep 2005 | - | $43.25 M(-15.0%) |
| Jun 2005 | - | $50.86 M(-13.9%) |
| Mar 2005 | - | $59.07 M(-10.6%) |
| Dec 2004 | $66.11 M(+87.9%) | $66.11 M(+5.7%) |
| Sep 2004 | - | $62.55 M(-8.7%) |
| Jun 2004 | - | $68.47 M(+74.1%) |
| Mar 2004 | - | $39.34 M(+11.8%) |
| Dec 2003 | $35.18 M(+118.4%) | $35.18 M |
| Dec 2002 | $16.11 M | - |
FAQ
- What is Alnylam Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual total assets year-on-year change?
- What is Alnylam Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly total assets year-on-year change?
What is Alnylam Pharmaceuticals annual total assets?
The current annual total assets of ALNY is $4.24 B
What is the all time high annual total assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual total assets is $4.24 B
What is Alnylam Pharmaceuticals annual total assets year-on-year change?
Over the past year, ALNY annual total assets has changed by +$410.10 M (+10.71%)
What is Alnylam Pharmaceuticals quarterly total assets?
The current quarterly total assets of ALNY is $4.24 B
What is the all time high quarterly total assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly total assets is $4.24 B
What is Alnylam Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, ALNY quarterly total assets has changed by +$410.10 M (+10.71%)